ÌìÃÀÓ°Ôº

Clinician researchers at Aarhus University Hospital in Denmark were early adopters of total-body multiparametric PET/CT imaging and are now working with Biograph Vision Quadraâ„¢. The team is focused on identifying the critical applications where the precise quantification of tracer dynamics can yield the most significant clinical benefits.

After receiving the diagnosis of neuroendocrine tumors, Glenda’s oncologist was unable to provide effective treatment options. Considering her disease burden and noting the progression of the tumors that were difficult to surgically remove, Glenda was referred for theranostics treatment. 

The European Association of Nuclear Medicine’s 37th Annual Meeting took place October 19–23, 2024, in Hamburg, Germany.

Occasionally, technological progress opens the door for completely new realms of research. Such is the case at Turku PET Centre in Finland,  where the Biograph Vision Quadraâ„¢ PET/CT is being used for total-body perfusion imaging — something that was simply not possible before.

As a true pioneer in the frontier in cancer treatment, The Comprehensive Cancer Center in Helsinki offers precision therapy personalized to the needs of each individual patient.

Professor Joseph R. Osborne, MD, PhD, chief of Molecular Imaging and therapeutics, and professor of radiology at a leading academic institution’s hospital in New York City, NY, USA, discusses theranostics and its rapidly expanding role in prostate cancer care.